Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4

Annals of Neurology

Volumn 81, Issue 2, 2017, Pages 193-198

  van Sonderen, Agnes ^a,b   Roelen, Dave L ^c   Stoop, Johannes A ^a   Verdijk, Robert M ^a   Haasnoot, Geert W ^c   Thijs, Roland D ^c,d   Wirtz, Paul W ^b   Schreurs, Marco W J ^a   Claas, Frans H J ^c   Sillevis Smitt, Peter A E ^a   Titulaer, Maarten J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR7 ANTIGEN; HLA DRB4 ANTIGEN; AUTOANTIBODY; LGI1 PROTEIN, HUMAN; PROTEIN;

ADULT; AGED; ALLELE; ALLERGIC ENCEPHALITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXPLORATORY RESEARCH; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; LEUCINE RICH GLIOMA INACTIVATED 1 ANTIBODY ENCEPHALITIS; MALE; MIDDLE AGED; NEUROPATHOLOGY; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; VERY ELDERLY; ENCEPHALITIS; GENETICS; IMMUNOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; ENCEPHALITIS; FEMALE; HLA-DR7 ANTIGEN; HLA-DRB4 CHAINS; HUMANS; MALE; MIDDLE AGED; PROTEINS;

EID: 85011373238     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24858     Document Type: Article

References (21)

1. Van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 2016;87:1449–1456.
2. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776–785.
3. Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 2013;265:75–81.
4. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426–430.
5. Gregersen PK, Kosoy R, Lee AT, et al. Risk for myasthenia gravis maps to a (151) Pro-->Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 2012;72:927–935.
6. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214–219.
7. Wirtz PW, Willcox N, van der Slik AR, et al. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J Neuroimmunol 2005;159:230–237.
8. Van Sonderen A, Schreurs MW, de Bruijn MA, et al. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology 2016;86:1692–1699.
9. Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011;18:19-27.
10. van Rooijen DE, Roelen DL, Verduijn W, et al. Genetic HLA associations in complex regional pain syndrome with and without dystonia. J Pain 2012;13:784–789.
11. Verduyn W, Doxiadis II, Anholts J, et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 1993;37:59–67.
12. Simabukuro MM, Petit-Pedrol M, Castro LH, et al. GABAA receptor and LGI1 antibody encephalitis in a patient with thymoma. Neurol Neuroimmunol Neuroinflamm 2015;2:e73.
13. Schlosstein L, Terasaki PI, Bluestone R, et al. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704–706.
14. Kobayashi K, Atoh M, Yagita A, et al. Crohn's disease in the Japanese is associated with the HLA-DRw53. Exp Clin Immunogenet 1990;7:101–108.
15. Zhou Y, Tan L, Que Q, et al. Study of association between HLA-DR4 and DR53 and autoantibody detection in rheumatoid arthritis. J Immunoassay Immunochem 2013;34:126–133.
16. Clot F, Gianfrani C, Babron MC, et al. HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides. Immunogenetics 1999;49:800–807.
17. Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, et al. The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis. Scand J Rheumatol 2004;33:318–322.
18. Arino H, Armangue T, Petit-Pedrol M, et al. Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 2016;87:1449–1456.
19. Huijbers MG, Querol LA, Niks EH, et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 2015;22:1151–1161.
20. Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 2014;13:575–586.
21. Roberts A, Perera S, Lang B, et al. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2 + flux in a human small cell carcinoma line. Nature 1985;317:737–739.